Search results
1 Stock I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 2 days agoThere are many positive things about Bristol Myers Squibb (NYSE: BMY) and its stock. It has a decently high dividend yield, it's one of the world's...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 17 hours agoBioPharma Dive is testing out a new format rounding up smaller updates from around the industry....
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously...
Benzinga· 6 days agoWednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s BMY Breyanzi...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 7 days agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
Bristol-Myers Squibb Co. (NYSE: BMY) Slashes -0.36%: What Could Be On The Way Going Forward? –...
Stocks Register· 7 days agoBristol-Myers Squibb Co. (NYSE:BMY) shares, rose in value on Wednesday, May 15, with the stock price down by -0.36% to the previous day’s close as strong demand from buyers drove the stock to ...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
1 Stock I Wouldn't Touch With a 10-Foot Pole
The Motley Fool via AOL· 2 days agoThere are many positive things about Bristol Myers Squibb (NYSE: BMY) and its stock. It has a decently high dividend yield, it's one of the world's largest pharmaceutical companies, and it makes ...
Cencora Provides Notice of Data Breach Affecting Bristol Myers Squibb Customers’ Information | JD...
JD Supra· 3 days agoOn May 17, 2024, Cencora, Inc. filed a notice of data breach with the Attorney General of Massachusetts after learning that a cyberattack targeting the company’s IT network resulted in an unauthorized ...
Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug...
Morningstar· 2 days agoUpdated Prescription Drug User Fee Act goal date of December 29, 2024 SAN DIEGO, May 21, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol ...
TD Cowen maintains $67 target on Bristol-Myers Squibb By Investing.com
Investing.com· 6 days agoOn Thursday, TD (TSX:TD) Cowen sustained its Hold rating on shares of Bristol-Myers Squibb Co....
